Attending the GHC Summit is how I got involved with iCannabinoid. I had just finished my Masters thesis about prescription drug abuse and misuse and the rest is history.

The Company is in the process of getting a third-party, independent valuation to establish the value of its CBN patent for the Canadian, U.S.,...The Company is in the process of getting a third-party, independent valuation to establish the value of its CBN patent for the Canadian, U.S., European, and global markets for the purpose of licensing other organizations to develop and sell CBN product lines under the protection of the Company’s U.S. patent.

For full article
www.otcmarkets.com/stock/CBIS/news/story Show more